Tag: Oncotarget

Oncotarget | Platelet-derived Growth Factor (PDGF) Cross-Signaling Via Non-Corresponding Receptors Indicates Bypassed Signaling in Colorectal Cancer

October 20, 2022

“The present study analyzed PDGFR and VEGFR expression in primary colon cancer tissues and CRC cell lines in order to better define their expression profiles. Furthermore, we analyzed putative PDGF… read more

Oncotarget

Oncotarget | In vitro Chemotherapy-associated Muscle Toxicity Attenuated With Nutritional Support, While Treatment Efficacy Retained

October 11, 2022

“Our in vitro study demonstrates the importance of specialized nutritional support and combining multiple nutrients to reach maximum effect to attenuate chemotherapy-associated muscle toxicity of skeletal muscle in cancer patients.”… read more

Oncotarget

Oncotarget | Targeted Elastin-like Polypeptide Fusion Protein for Near-infrared Imaging of Human and Canine Urothelial Carcinoma

September 8, 2022

“We have developed a peptide-based NIR probe, Cy5.5-N24-EGF, that shows high EGFR-specific binding specificity in canine and human UC in vitro and ex vivo.” Listen to an audio version of… read more

Figure 2: TMB distribution in non-small cell lung cancer

Oncotarget

Mutational Burden in Lung Cancer Studied in Multisite Cohort

April 25, 2022

Listen to an audio version of this press release BUFFALO, NY-April 25, 2022 – A new research paper, entitled, “Real-world survival analysis by tumor mutational burden in non-small cell lung… read more

Dr. Stanley Lipkowitz and Dr. Yoshimi Endo Greer

Oncotarget

Behind the Study: How ONC201 Kills Breast Cancer Cells

April 22, 2022

Dr. Stanley Lipkowitz and Dr. Yoshimi Endo Greer from the Women’s Malignancies Branch at the National Cancer Institute discuss a research paper they co-authored that was published by Oncotarget in… read more

Oncotarget

Impact Journals at AACR Annual Meeting 2022

March 28, 2022

Listen to an audio version of this announcement BUFFALO, NY-March 28, 2022 – Impact Journals publishes scholarly journals in biomedical sciences with a focus on all areas of cancer and aging research. Impact… read more

Oncotarget

Behind the Study: Targeting Stem Cells in Non-Small Cell Lung Cancer

March 25, 2022

Dr. Beatrice Aramini and Dr. Valentina Masciale from the University of Modena and Reggio Emilia details a 2020 research paper she co-authored and published by Oncotarget, entitled, “CD44+/EPCAM+ cells detect a… read more

Oncotarget

Oncotarget’s Top 10 Most-Viewed Papers in 2021

January 21, 2022

Read the 10 most-viewed oncology-focussed papers on Oncotarget.com in 2021. — Listen to an audio version of this post #10: Metformin and berberine, two versatile drugs in treatment of common metabolic… read more

Oncotarget

Open-Access Oncotarget Shifts to Continuous Publishing

January 6, 2022

As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing. — Listen to an audio version of this announcement BUFFALO, NY, January 6, 2022 – Since its inception in… read more

Oncotarget

Captain of Team Open Access Rides Again for Cancer Research

August 16, 2021

For the past four summers, Impact Journals has sponsored Team Open Access in the Ride for Roswell. The peloton has been captained by Sergei Kurenov, who is the Director of Surgical Simulation… read more